Valuing condition-specific health states using simulation contact lenses

Value in Health

Volumn 12, Issue 5, 2009, Pages 793-799

  Czoski Murray, Carolyn ^a   Carlton, Jill ^a   Brazier, John ^a   Young, Tracey ^a   Papo, Natalie L ^a   Kang, Hyong Kwon ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Age related macular degeneration; Health related quality of life; Quality of life; United Kingdom

Indexed keywords

ADULT; ARTICLE; CONTACT LENS; DISEASE SIMULATION; EUROPEAN QUALITY OF LIFE QUESTIONNAIRE 5 DIMENSIONS; HEALTH STATUS; HEALTH UTILITIES INDEX; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIFE INDEX; RETINA MACULA AGE RELATED DEGENERATION; UNITED KINGDOM; VISUAL ACUITY; VISUAL IMPAIRMENT;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; CONTACT LENSES; COST OF ILLNESS; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MACULAR DEGENERATION; MALE; MIDDLE AGED; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; VISUAL ACUITY; YOUNG ADULT;

EID: 67649983163     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2009.00527.x     Document Type: Article

References (20)

1. Brazier J, Akehurst R, Brennan A, et al. Should patients have a greater role in valuing health states? Appl Health Econ Health Policy 2005 4 : 201 8.
2. Insinga RP, Fryback DG. Understanding differences between self-ratings and population ratings for health in the EuroQol. Qual Life Res 2003 12 : 611 9.
3. Ubel PA, Loewenstein G, Jepson C. Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Qual Life Res 2003 12 : 599 607. (Pubitemid 37094023)
4. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. Oxford : Oxford University Press, 1996.
5. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997 35 : 1095 108.
6. Feeny DH, Furlong WJ, Torrance GW, et al. Multiattribute and single-attribute utility function: the Health Utility Index Mark 3 system. Med Care 2002 40 : 113 28.
7. Brazier J, Roberts J, Deverill M. The estimation of a preference-based single index measure for health from the SF-36. J Health Econ 2002 21 : 271 92.
8. McNeil BJ, Weichselbaum R, Pauker SG. Speech and survival: tradeoffs between quality and quantity in laryngeal cancer. N Engl J Med 1981 3005 : 982 7.
9. Morss SE, Lenert LA, Faustman WO. The side effects of antipsychotic drugs and patients' quality of life: patient education and preference assessment with computers and multimedia. Proc Annu Symp Comput Appl Med Care 1993 17 21.
10. Meads C, Salas C, Roberts T, et al. Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation. Health Technol Assess 2003 7 : v vi, 1 98.
11. Brown GC, Sharma S, Brown MM, Kistler J. Utility values and age-related macular degeneration. Arch Ophthalmol 2000 118 : 47 51. (Pubitemid 30036436)
12. Espallargues M, Czoski-Murray C, Bansback N, et al. The impact of age related macular degeneration on health state utility values. Invest Ophthalmol Vis Sci 2005 46 : 4016 23.
13. Bansback N, Brazier J, Davies S. Using contrast sensitivity to estimate the cost effectiveness of verteporfin in patients with predominantly classic age related macular degeneration. Eye 2007 21 : 1455 163.
14. Aballéa S, Tsuchiya A. Seeing for yourself: feasibility study towards valuing visual impairment using simulation spectacles. Health Econ 2007 16 : 537 43.
15. Dolan P, Gudex C, Kind P, Williams A. Valuing health states: a comparison of methods. J Health Econ 1996 15 : 209 31.
16. Steinberg EP, Tielsch JM, Schein OD, et al. The VF-14. An index of functional impairment in patients with cataract. Arch Ophthalmol 1994 112 : 630 8.
17. StataCorp. Statistical Software: Release 9.2. College Station, TX : Stata Corporation, 2007.
18. Office of National Statistics. Available from: http://www.statistics.gov. uk [Accessed April 18, 2008 J. Decision validity should determine whether generic or condition-specific HRQOL measure is used in health care decisions. Health Econ 2002 11 : 1 8.
19. Brazier JE, Ratcliffe J, Tsuchiya A, Solomon J. Measuring and Valuing Health for Economic Evaluation. Oxford : Oxford University Press, 2007.
20. Menzel P, Dolan P, Richardson J, Olsen JA. The role of adaptation to disability and disease in health state valuation: a preliminary normative analysis. Soc Sci Med 2002 55 : 2149 58.